» Articles » PMID: 25309615

A Rheological Study of Biodegradable Injectable PEGMC/HA Composite Scaffolds

Overview
Journal Soft Matter
Specialties Biochemistry
Chemistry
Date 2014 Oct 14
PMID 25309615
Citations 21
Authors
Affiliations
Soon will be listed here.
Abstract

Injectable biodegradable hydrogels, which can be delivered in a minimally invasive manner and formed , have found a number of applications in pharmaceutical and biomedical applications, such as drug delivery and tissue engineering. We have recently developed an crosslinkable citric acid-based biodegradable poly (ethylene glycol) maleate citrate (PEGMC)/hydroxyapatite (HA) composite, which shows promise for use in bone tissue engineering. In this study, the mechanical properties of the PEGMC/HA composites were studied in dynamic linear rheology experiments. Critical parameters such as monomer ratio, crosslinker, initiator, and HA concentrations were varied to reveal their effect on the extent of crosslinking as they control the mechanical properties of the resultant gels. The rheological studies, for the first time, allowed us investigating the physical interactions between HA and citric acid-based PEGMC. Understanding the viscoelastic properties of the injectable gel composites is crucial in formulating suitable injectable PEGMC/HA scaffolds for bone tissue engineering, and should also promote the other biomedical applications based on citric acid-based biodegradable polymers.

Citing Articles

The use of hydrogel microspheres as cell and drug delivery carriers for bone, cartilage, and soft tissue regeneration.

Lin C, Srioudom J, Sun W, Xing M, Yan S, Yu L Biomater Transl. 2024; 5(3):236-256.

PMID: 39734701 PMC: 11681182. DOI: 10.12336/biomatertransl.2024.03.003.


Extracellular vesicle therapeutics for cardiac repair.

Hu Y, Zhang W, Ali S, Takeda K, Vahl T, Zhu D J Mol Cell Cardiol. 2024; 199:12-32.

PMID: 39603560 PMC: 11788051. DOI: 10.1016/j.yjmcc.2024.11.005.


PEG-Based Hydrogel Coatings: Design Tools for Biomedical Applications.

Wancura M, Nkansah A, Robinson A, Toubbeh S, Talanker M, Jones S Ann Biomed Eng. 2023; 52(7):1804-1815.

PMID: 36774427 DOI: 10.1007/s10439-023-03154-9.


Development of Biodegradable Osteopromotive Citrate-Based Bone Putty.

Tan X, Gerhard E, Wang Y, Tran R, Xu H, Yan S Small. 2022; 18(36):e2203003.

PMID: 35717669 PMC: 9463100. DOI: 10.1002/smll.202203003.


Engineering multifunctional bioactive citrate-based biomaterials for tissue engineering.

Wang M, Xu P, Lei B Bioact Mater. 2022; 19:511-537.

PMID: 35600971 PMC: 9096270. DOI: 10.1016/j.bioactmat.2022.04.027.


References
1.
Habraken W, Wolke J, Jansen J . Ceramic composites as matrices and scaffolds for drug delivery in tissue engineering. Adv Drug Deliv Rev. 2007; 59(4-5):234-48. DOI: 10.1016/j.addr.2007.03.011. View

2.
Chang C, Liao T, Hsu Y, Fang H, Chen C, Lin F . A poly(propylene fumarate)--calcium phosphate based angiogenic injectable bone cement for femoral head osteonecrosis. Biomaterials. 2010; 31(14):4048-55. DOI: 10.1016/j.biomaterials.2010.01.124. View

3.
Gyawali D, Nair P, Zhang Y, Tran R, Zhang C, Samchukov M . Citric acid-derived in situ crosslinkable biodegradable polymers for cell delivery. Biomaterials. 2010; 31(34):9092-105. PMC: 2954112. DOI: 10.1016/j.biomaterials.2010.08.022. View

4.
Dey J, Xu H, Shen J, Thevenot P, Gondi S, Nguyen K . Development of biodegradable crosslinked urethane-doped polyester elastomers. Biomaterials. 2008; 29(35):4637-49. PMC: 2747515. DOI: 10.1016/j.biomaterials.2008.08.020. View

5.
Moursi A, Winnard A, Winnard P, Lannutti J, Seghi R . Enhanced osteoblast response to a polymethylmethacrylate-hydroxyapatite composite. Biomaterials. 2002; 23(1):133-44. DOI: 10.1016/s0142-9612(01)00088-6. View